Us fda

Sun Pharma has fared worse compared to its peers and the broad market. Graphic: Naveen Kumar Saini/Mint

Sun Pharma: One down, Halol to go

3 min read . 23 Mar 2018
Aurobindo Pharma’s shares closed with a loss of 3.7% as investors feared it may face delays in resolving the issue. Graphic: Naveen Kumar Saini/Mint

US FDA: a risk that keeps on giving

3 min read . 06 Mar 2018